Published 8th March 2016

Puridify establishes Scientific Advisory Board

Portfolio company Puridify, which is devceloping novel bioprocessing purification technologies for industrial biomolecule manufacture, has established a Scientific Advisory Board (SAB) to guide the company's development of its proprietary nanofibre purification platform, FIbroSelect.

The SAB comprises the following members:

  • Dr Daniel Bracewell
  • Dr Barry Buckland
  • Dr Karol Lacki
  • Dr Will Lewis
  • Dr John Liddell

Oliver Hardick, CEO of Puridify, said:

“We are very pleased to have the support of such a distinguished mix of individuals whose input from their complementary backgrounds will help accelerate the commercialisation of our single-use purification technology.”

Click here to learn more about the SAB